MSF Responds to EMA approval of new tuberculosis drug delamanid
November 22, 2013On November 22, 2013, the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) recommended granting a conditional marketing authorisation for delamanid, only the second new TB drug to be developed in 50 years. It is hoped...
Read more
Dr Joanne Liu new International President of MSF
October 1, 2013Geneva, October 1, 2013. Today, Médecins Sans Frontières (MSF) welcomes Dr Joanne Liu as the new International President of the medical humanitarian organisation. Dr Liu was elected President during MSF’s International General Assembly in June 2013. "Today’s challenges in MSF...
Read more
Global Vaccination Community Neglecting Refugee Children
August 8, 2013GENEVA/NEW YORK AUGUST 8, 2013—As Doctors Without Borders/Médecins Sans Frontières (MSF) begins vaccinating children against pneumonia in a refugee camp in South Sudan, the international medical humanitarian organization warned today that the global vaccination community is neglecting to provide new...
Read more
